Cargando…

Emission-particle-induced ventilatory abnormalities in a rat model of pulmonary hypertension.

Preexistent cardiopulmonary disease in humans appears to enhance susceptibility to the adverse effects of ambient particulate matter. Previous studies in this laboratory have demonstrated enhanced inflammation and mortality after intratracheal instillation (IT) and inhalation (INH) of residual oil f...

Descripción completa

Detalles Bibliográficos
Autores principales: Gardner, Sarah Y, McGee, John K, Kodavanti, Urmila P, Ledbetter, Allen, Everitt, Jeffrey I, Winsett, Darrell W, Doerfler, Donald L, Costa, Daniel L
Formato: Texto
Lenguaje:English
Publicado: 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1242015/
https://www.ncbi.nlm.nih.gov/pubmed/15175175
_version_ 1782125565133717504
author Gardner, Sarah Y
McGee, John K
Kodavanti, Urmila P
Ledbetter, Allen
Everitt, Jeffrey I
Winsett, Darrell W
Doerfler, Donald L
Costa, Daniel L
author_facet Gardner, Sarah Y
McGee, John K
Kodavanti, Urmila P
Ledbetter, Allen
Everitt, Jeffrey I
Winsett, Darrell W
Doerfler, Donald L
Costa, Daniel L
author_sort Gardner, Sarah Y
collection PubMed
description Preexistent cardiopulmonary disease in humans appears to enhance susceptibility to the adverse effects of ambient particulate matter. Previous studies in this laboratory have demonstrated enhanced inflammation and mortality after intratracheal instillation (IT) and inhalation (INH) of residual oil fly ash (ROFA) in a rat model of pulmonary hypertension induced by monocrotaline (MCT). The present study was conducted to examine the effects of ROFA in this model on ventilatory function in unanesthetized, unrestrained animals. Sixty-day-old male CD rats were injected with MCT (60 mg/kg) or vehicle (VEH) intraperitoneally 10 days before IT of ROFA (8.3 mg/kg) or saline (SAL) (control) or nose-only INH of ROFA [15 mg/m3 for 6 hr on 3 consecutive days or air (control)]. At 24 and 72 hr after exposure, rats were studied individually in a simultaneous gas uptake/whole-body plethysmograph. Lungs were removed at 72 hr for histology. Pulmonary test results showed that tidal volume (VT) decreased 24 hr after IT of ROFA in MCT-treated rats. Breathing frequency, minute volume (VE), and the ventilatory equivalent for oxygen increased in MCT- and VEH-treated rats 24 hr after IT or INH of ROFA and remained elevated 72 hr post-IT. O2 uptake (VO2) decreased after IT of ROFA in MCT-treated rats. Carbon monoxide uptake decreased 24 hr after IT of ROFA, returning to control values in VEH-treated rats but remaining low in MCT-treated rats 72 hr post-IT. ROFA exposure induced histologic changes and abnormalities in several ventilatory parameters, many of which were enhanced by MCT treatment.
format Text
id pubmed-1242015
institution National Center for Biotechnology Information
language English
publishDate 2004
record_format MEDLINE/PubMed
spelling pubmed-12420152005-11-08 Emission-particle-induced ventilatory abnormalities in a rat model of pulmonary hypertension. Gardner, Sarah Y McGee, John K Kodavanti, Urmila P Ledbetter, Allen Everitt, Jeffrey I Winsett, Darrell W Doerfler, Donald L Costa, Daniel L Environ Health Perspect Research Article Preexistent cardiopulmonary disease in humans appears to enhance susceptibility to the adverse effects of ambient particulate matter. Previous studies in this laboratory have demonstrated enhanced inflammation and mortality after intratracheal instillation (IT) and inhalation (INH) of residual oil fly ash (ROFA) in a rat model of pulmonary hypertension induced by monocrotaline (MCT). The present study was conducted to examine the effects of ROFA in this model on ventilatory function in unanesthetized, unrestrained animals. Sixty-day-old male CD rats were injected with MCT (60 mg/kg) or vehicle (VEH) intraperitoneally 10 days before IT of ROFA (8.3 mg/kg) or saline (SAL) (control) or nose-only INH of ROFA [15 mg/m3 for 6 hr on 3 consecutive days or air (control)]. At 24 and 72 hr after exposure, rats were studied individually in a simultaneous gas uptake/whole-body plethysmograph. Lungs were removed at 72 hr for histology. Pulmonary test results showed that tidal volume (VT) decreased 24 hr after IT of ROFA in MCT-treated rats. Breathing frequency, minute volume (VE), and the ventilatory equivalent for oxygen increased in MCT- and VEH-treated rats 24 hr after IT or INH of ROFA and remained elevated 72 hr post-IT. O2 uptake (VO2) decreased after IT of ROFA in MCT-treated rats. Carbon monoxide uptake decreased 24 hr after IT of ROFA, returning to control values in VEH-treated rats but remaining low in MCT-treated rats 72 hr post-IT. ROFA exposure induced histologic changes and abnormalities in several ventilatory parameters, many of which were enhanced by MCT treatment. 2004-06 /pmc/articles/PMC1242015/ /pubmed/15175175 Text en
spellingShingle Research Article
Gardner, Sarah Y
McGee, John K
Kodavanti, Urmila P
Ledbetter, Allen
Everitt, Jeffrey I
Winsett, Darrell W
Doerfler, Donald L
Costa, Daniel L
Emission-particle-induced ventilatory abnormalities in a rat model of pulmonary hypertension.
title Emission-particle-induced ventilatory abnormalities in a rat model of pulmonary hypertension.
title_full Emission-particle-induced ventilatory abnormalities in a rat model of pulmonary hypertension.
title_fullStr Emission-particle-induced ventilatory abnormalities in a rat model of pulmonary hypertension.
title_full_unstemmed Emission-particle-induced ventilatory abnormalities in a rat model of pulmonary hypertension.
title_short Emission-particle-induced ventilatory abnormalities in a rat model of pulmonary hypertension.
title_sort emission-particle-induced ventilatory abnormalities in a rat model of pulmonary hypertension.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1242015/
https://www.ncbi.nlm.nih.gov/pubmed/15175175
work_keys_str_mv AT gardnersarahy emissionparticleinducedventilatoryabnormalitiesinaratmodelofpulmonaryhypertension
AT mcgeejohnk emissionparticleinducedventilatoryabnormalitiesinaratmodelofpulmonaryhypertension
AT kodavantiurmilap emissionparticleinducedventilatoryabnormalitiesinaratmodelofpulmonaryhypertension
AT ledbetterallen emissionparticleinducedventilatoryabnormalitiesinaratmodelofpulmonaryhypertension
AT everittjeffreyi emissionparticleinducedventilatoryabnormalitiesinaratmodelofpulmonaryhypertension
AT winsettdarrellw emissionparticleinducedventilatoryabnormalitiesinaratmodelofpulmonaryhypertension
AT doerflerdonaldl emissionparticleinducedventilatoryabnormalitiesinaratmodelofpulmonaryhypertension
AT costadaniell emissionparticleinducedventilatoryabnormalitiesinaratmodelofpulmonaryhypertension